Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "CANCERS"

Add to list
- Journal Article
- A1
- open access
MAIT cells come to the rescue in cancer immunotherapy?

Zuzanna Łukasik, Dirk Elewaut (UGent) and Koen Venken (UGent)

(2020) CANCERS. 12(2).
Add to list
- Journal Article
- A1
- open access
A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Elise De Bleser (UGent) , Ruben Willems (UGent) , Karel Decaestecker (UGent) , Lieven Annemans (UGent) , Aurélie De Bruycker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Filip Ameye, Ignace Billiet, Steven Joniau, et al.

(2020) CANCERS. 12(1).
Add to list
- Journal Article
- A1
- open access
Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer

Carolina Velázquez, De Leeneer Kim, Eva M. Esteban-Cardeñosa, Francisco Avila Cobos, Enrique Lastra, Luis E. Abella, Virginia de la Cruz, Carmen D. Lobatón, Kathleen Claes (UGent) , Mercedes Durán, et al.

(2020) Cancers. 12.
Add to list
- Journal Article
- A1
- open access
The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance

Nele Loret (UGent) , Hannelore Denys (UGent) , Philippe Tummers (UGent) and Geert Berx (UGent)

(2019) CANCERS. 11(6).
Add to list
- Journal Article
- A1
- open access
Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis

Molood Shariati (UGent) , Wouter Willaert (UGent) , Wim Ceelen (UGent) , Stefaan De Smedt (UGent) and Katrien Remaut (UGent)

(2019) CANCERS. 11(7).
Add to list
- Journal Article
- A1
- open access
The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

Sylvia Faict, Inge Oudaert, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens (UGent) , Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, et al.

(2019) CANCERS. 11(12).
Add to list
- Journal Article
- A1
- open access
Mononuclear but not polymorphonuclear phagocyte depletion increases circulation times and improves mammary tumor-homing efficiency of donor bone marrow-derived monocytes

Francis Combes (UGent) , Alexandros Marios Sofias, Séan Mc Cafferty (UGent) , Hanne Huysmans (UGent) , Joyca De Temmerman (UGent) , Sjoerd Hak, Evelyne Meyer (UGent) and Niek Sanders (UGent)

(2019) CANCERS. 11(11).
Add to list
- Journal Article
- A1
- open access
Standardization of somatic variant classifications in solid and haematological tumours by a two-Level approach of biological and clinical classes : an Initiative of the Belgian ComPerMed Expert Panel

Guy Froyen, Marie Le Mercier, Els Lierman, Karl Vandepoele (UGent) , Friedel Nollet, Elke Boone, Joni Van der Meulen (UGent) , Koen Jacobs, Suzan Lambin, Sara Vander Borght, et al.

(2019) CANCERS. 11(12).
Add to list
- Journal Article
- A1
- open access
Combination of EGFR inhibitor lapatinib and MET inhibitor foretinib inhibits migration of triple negative breast cancer cell lines

Aleksandra Simiczyjew, Ewelina Dratkiewicz, Marleen Van Troys (UGent) , Christophe Ampe (UGent) , Ilona Styczeń and Dorota Nowak

(2018) CANCERS. 10(9).

Academic Bibliography

MAIT cells come to the rescue in cancer immunotherapy?

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer

The role of epithelial-to-mesenchymal plasticity in ovarian cancer progression and therapy resistance

Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis

The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

Mononuclear but not polymorphonuclear phagocyte depletion increases circulation times and improves mammary tumor-homing efficiency of donor bone marrow-derived monocytes

Standardization of somatic variant classifications in solid and haematological tumours by a two-Level approach of biological and clinical classes : an Initiative of the Belgian ComPerMed Expert Panel

Combination of EGFR inhibitor lapatinib and MET inhibitor foretinib inhibits migration of triple negative breast cancer cell lines

Contents

Support

Contact